Published online Jul 21, 2021. doi: 10.3748/wjg.v27.i27.4481
Peer-review started: January 17, 2021
First decision: February 23, 2021
Revised: March 29, 2021
Accepted: June 25, 2021
Article in press: June 25, 2021
Published online: July 21, 2021
Detection of prevalence and development of osteopenia or osteoporosis in patients with inflammatory bowel disease using only bone mineral density could be inappropriate to detect all individuals at risk for osteoporosis. Numerous patients could remain undetected by using only bone mineral density as a screening method, especially in patients with ulcerative colitis. Therefore, trabecular bone score should be used as a complementary method.
Core Tip: Lower body mass index is a predictor of osteoporosis in patients with inflammatory bowel disease however, fracture risk can be increased desite normal bone mineral density. Therefore, use of trabecular bone score would ensure recruitment of individuals with normal bone mineral density at increased risk of fractures in trials.